Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRENE.L Regulatory News (RENE)

  • There is currently no data for RENE

Director/PDMR Shareholding

26 Apr 2006 17:17

ReNeuron Group plc26 April 2006 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. (3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24. (4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes in block capital letters. 1. Name of the issuer RENEURON GROUP PLC 2. State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) SECTION 324 OF THE COMPANIES ACT 1985 3. Name of person discharging managerial responsibilities/director KENNY POLLOCK 4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A 5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest PERSON NAMED IN 3 ABOVE 6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares ORDINARY SHARES 7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them KENNY POLLOCK 8. State the nature of the transaction ON MARKET PURCHASE 9. Number of shares, debentures or financial instruments relating to shares acquired 16,962 10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) 0.02% 11. Number of shares, debentures or financial instruments relating to shares disposed N/A 12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A 13. Price per share or value of transaction 13.75P 14. Date and place of transaction 25 APRIL 2006, LONDON 15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 16,962 16. Date issuer informed of transaction 26 APRIL 2006 If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes 17. Date of grant 18. Period during which or date on which it can be exercised 19. Total amount paid (if any) for grant of the option 20. Description of shares or debentures involved (class and number) 21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise 22. Total number of shares or debentures over which options held following notification 23. Any additional information 24. Name of contact and telephone number for queries Name and signature of duly authorised officer of issuer responsible for making notification Date of notification This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Sep 20077:00 amRNSResearch Update
20th Aug 20077:02 amRNSRe: AIM Rule 26
10th Aug 200712:53 pmRNSHolding(s) in Company
8th Aug 20075:27 pmRNSDirector/PDMR Shareholding
8th Aug 20074:59 pmRNSDirector/PDMR Shareholding
8th Aug 20074:58 pmRNSDirector/PDMR Shareholding
8th Aug 20074:56 pmRNSDirector/PDMR Shareholding
8th Aug 20074:44 pmRNSDirector/PDMR Shareholding
2nd Aug 200712:12 pmRNSIncrease in Share Capital
27th Jul 20077:01 amRNSAcquisition
20th Jul 200711:17 amRNSNotice of AGM
27th Jun 20077:01 amRNSFinal Results
22nd Jun 20077:01 amRNSResearch Update
15th Jun 200712:10 pmRNSNotice of Results
15th Jun 20077:01 amRNSISSCR Conference
31st May 20077:01 amRNSRe: New Data
18th May 20077:00 amRNSRe: Collaboration
10th May 20071:04 pmRNSRodman & Renshaw Conference
1st May 200710:50 amRNSRe: Stem Cell Conference
25th Apr 20074:46 pmRNSAdvanced Therapies Regulation
17th Apr 20077:01 amRNSPatent Grant
12th Apr 200712:09 pmRNSHolding(s) in Company
12th Apr 20077:01 amRNSHolding(s) in Company
23rd Mar 200710:57 amRNSHolding(s) in Company
6th Mar 20072:27 pmRNSRe: Stem Cell conference
26th Feb 20078:00 amRNSRevenue-Sharing Agreement
16th Feb 20077:00 amRNSAllotment of Shares
13th Feb 20077:01 amRNSHolding(s) in Company
12th Feb 20071:00 pmRNSReNeuron to Present
6th Feb 200711:24 amRNSHolding(s) in Company
6th Feb 20077:01 amRNSFundraising
31st Jan 20079:38 amRNSShares notification
31st Jan 20079:37 amRNSShares notification
24th Jan 20077:01 amRNSSecures Funding
18th Jan 20077:01 amRNSHolding(s) in Company
12th Jan 200710:02 amRNSRegulatory Update
9th Jan 200712:38 pmRNSHolding(s) in Company
9th Jan 20077:01 amRNSRegulatory Update
27th Dec 20067:01 amRNSTotal Voting Rights
19th Dec 20067:00 amRNSDirector/PDMR Shareholding
19th Dec 20067:00 amRNSDirector/PDMR Shareholding
14th Dec 20067:01 amRNSRe Exercise of Warrants
8th Dec 20064:21 pmRNSHolding(s) in Company
7th Dec 200611:21 amRNSDirector/PDMR S/hldg-Replace
7th Dec 20067:02 amRNSDirector/PDMR Shareholding
7th Dec 20067:02 amRNSDirector/PDMR Shareholding
7th Dec 20067:02 amRNSDirector/PDMR Shareholding
7th Dec 20067:02 amRNSDirector/PDMR Shareholding
7th Dec 20067:02 amRNSDirector/PDMR Shareholding
7th Dec 20067:02 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.